Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Ahlner

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Forensic Science International|September 21, 2010
Influence of pre-analytical conditions on the interpretation of zopiclone concentrations in whole bloodGunnel H Nilsson, Fredrik C Kugelberg, Johan Ahlner, et al.
Forensic Science International|May 4, 2010
Stability tests of zopiclone in whole bloodGunnel H Nilsson, Fredrik C Kugelberg, Robert Kronstrand, et al.
Journal of Analytical Toxicology|May 3, 2014
Quantitative analysis of zopiclone, N-desmethylzopiclone, zopiclone N-oxide and 2-amino-5-chloropyridine in urine using LC-MS-MSGunnel H Nilsson, Fredrik C Kugelberg, Johan Ahlner, et al.
Basic & Clinical Pharmacology & Toxicology|July 27, 2006
Sustained citalopram treatment in experimental hepatic encephalopathy: effects on entrainment to the light-dark cycle and melatoninFredrik C Kugelberg, Gustav Apelqvist, Björn Carlsson, et al.
European Journal of Clinical Pharmacology|November 5, 2018
Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem studyJonas Forsman, Thomas Masterman, Johan Ahlner, et al.
Chirality|September 18, 2010
Cytochrome P450-dependent disposition of the enantiomers of citalopram and its metabolites: in vivo studies in Sprague-Dawley and Dark Agouti ratsMaria Kingbäck, Björn Carlsson, Johan Ahlner, et al.
Therapeutic Drug Monitoring|October 1, 2008
Therapeutic drug monitoring of ziprasidone in a clinical treatment settingMaria D Chermá, Margareta Reis, Staffan Hägg, et al.
Journal of Analytical Toxicology|November 13, 2004
Postmortem redistribution of the enantiomers of citalopram and its metabolites: an experimental study in ratsFredrik C Kugelberg, Henrik Druid, Björn Carlsson, et al.
Maturitas|December 14, 2004
Hormone replacement therapy in the menopause. Structure and content of risk talkMikael Hoffmann, Lotta Lindh-Astrand, Johan Ahlner, et al.
Journal of Analytical Toxicology|October 31, 2009
Urinary detection times and excretion patterns of flunitrazepam and its metabolites after a single oral doseMalin Forsman, Ingrid Nyström, Markus Roman, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Forensic Science International|September 21, 2010
Influence of pre-analytical conditions on the interpretation of zopiclone concentrations in whole bloodGunnel H Nilsson, Fredrik C Kugelberg, Johan Ahlner, et al.
Forensic Science International|May 4, 2010
Stability tests of zopiclone in whole bloodGunnel H Nilsson, Fredrik C Kugelberg, Robert Kronstrand, et al.
Journal of Analytical Toxicology|May 3, 2014
Quantitative analysis of zopiclone, N-desmethylzopiclone, zopiclone N-oxide and 2-amino-5-chloropyridine in urine using LC-MS-MSGunnel H Nilsson, Fredrik C Kugelberg, Johan Ahlner, et al.
Basic & Clinical Pharmacology & Toxicology|July 27, 2006
Sustained citalopram treatment in experimental hepatic encephalopathy: effects on entrainment to the light-dark cycle and melatoninFredrik C Kugelberg, Gustav Apelqvist, Björn Carlsson, et al.
European Journal of Clinical Pharmacology|November 5, 2018
Selective serotonin re-uptake inhibitors and the risk of violent suicide: a nationwide postmortem studyJonas Forsman, Thomas Masterman, Johan Ahlner, et al.
Chirality|September 18, 2010
Cytochrome P450-dependent disposition of the enantiomers of citalopram and its metabolites: in vivo studies in Sprague-Dawley and Dark Agouti ratsMaria Kingbäck, Björn Carlsson, Johan Ahlner, et al.
Therapeutic Drug Monitoring|October 1, 2008
Therapeutic drug monitoring of ziprasidone in a clinical treatment settingMaria D Chermá, Margareta Reis, Staffan Hägg, et al.
Journal of Analytical Toxicology|November 13, 2004
Postmortem redistribution of the enantiomers of citalopram and its metabolites: an experimental study in ratsFredrik C Kugelberg, Henrik Druid, Björn Carlsson, et al.
Maturitas|December 14, 2004
Hormone replacement therapy in the menopause. Structure and content of risk talkMikael Hoffmann, Lotta Lindh-Astrand, Johan Ahlner, et al.
Journal of Analytical Toxicology|October 31, 2009
Urinary detection times and excretion patterns of flunitrazepam and its metabolites after a single oral doseMalin Forsman, Ingrid Nyström, Markus Roman, et al.
Pageof 9